Ultra-scalable bioproduction as a service to scale the production of high-value molecules.Learn more about our Technology
Core Biogenesis uses plants as biofactories to scale the production of high-value molecules. Our Ultra-scalable bioproduction as a service (UBaaS) platform accelerates mass production and increases yields, while driving down costs.
By unlocking a new paradigm in recombinant molecule production, we are helping build a more sustainable future.
We believe that everything manufactured today will be biomanufactured tomorrow. Our technology unlocks the promises of the bioeconomy.
Our Ultra-scalable bioproduction as a service (UBaaS) platform simplifies and accelerates the mass-production and purification of sustainable, high-performance recombinant molecules, while driving production costs down.
Our UBaaS platform isolates your molecules to a specific plant compartment, making extraction faster, more scalable, and less expensive.
The Core Biogenesis Ultra-scalable bioproduction as a service (UBaaS) platform enables the rapid mass-production of high-valuable recombinant molecules that will unlock the promises of the bioeconomy.
Growth factors for cell-based products
Interleukins for cell therapy manufacturing
Enzymes for mRNA manufacturing
Get in touch
Core BiogenesisStation F, 5 Parvis Alan Turing,
Core BiogenesisGenopole, 4 Rue Pierre Fontaine,